These lab-made possibilities were not produced with leisure use in mind. From the nineteen nineties, John W. Huffman and a team of fellow chemists at Clemson University established many of the initially formulation for synthetic cannabinoid receptor agonists (SCRAs), a relatives of substances that imitate the physiological and psychological impacts